Delivery Platform


For each of these two routes of administration, our strategy is to develop platform technologies that would be used for multiple individual vaccines or combination vaccines.  

For the selection of disease targets and technology providers for vaccine development, Hilleman Laboratories aims to identify vaccines that are administered orally and through parenteral routes.


Orally administered vaccine platform

  • The oral vaccine platform aims to develop heat-stable, easy-to-use affordable vaccines for developing countries. We aim to develop lyophilized, spray dried and proprietary technologies that can be used as platforms for vaccine delivery.



Parenteral vaccine delivery platform

  • We are conducting analyses of parenteral vaccine delivery on two fronts:
    • We are obtaining information on the desirability of easy-to-deliver vaccines in public health programs.
    • We are conducting a detailed analysis on available transformational technologies in parenteral vaccine delivery.